Literature DB >> 19388719

How do we safely treat depression in children, adolescents and young adults?

Jon Jureidini1.   

Abstract

Increasing concerns about the safety and efficacy of antidepressant drugs for children, adolescents and young adults have been countered by claims that reduced prescribing of antidepressants may have dangerous consequences. This leaves clinicians unsure as to how to weigh up the evidence and apply it to their patients. This paper promotes an approach of evaluating the evidence in each study according to the importance of the outcomes being measured in that study. It finds that on important measures such as mortality, hospitalization and quality of life, the evidence is unfavourable for antidepressants in this population. Here, an approach is suggested that primary care physicians might adopt with their depressed young patients. Through a combination of 'watchful waiting' and physical and emotional rehabilitation, physicians can actively intervene without reliance on medication or psychotherapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19388719     DOI: 10.2165/00002018-200932040-00002

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  40 in total

1.  Suicide rates in short-term randomized controlled trials of newer antidepressants.

Authors:  Tarek A Hammad; Thomas P Laughren; Judith A Racoosin
Journal:  J Clin Psychopharmacol       Date:  2006-04       Impact factor: 3.153

2.  Outcomes-based drug coverage in British Columbia.

Authors:  Steven Morgan; Ken Bassett; Barbara Mintzes
Journal:  Health Aff (Millwood)       Date:  2004 May-Jun       Impact factor: 6.301

3.  Suicidal adverse events in pediatric randomized, controlled clinical trials of antidepressant drugs are associated with active drug treatment: a meta-analysis.

Authors:  Andrew D Mosholder; Mary Willy
Journal:  J Child Adolesc Psychopharmacol       Date:  2006 Feb-Apr       Impact factor: 2.576

Review 4.  Exercise in prevention and treatment of anxiety and depression among children and young people.

Authors:  L Larun; L V Nordheim; E Ekeland; K B Hagen; F Heian
Journal:  Cochrane Database Syst Rev       Date:  2006-07-19

5.  A randomized, double-blind, placebo-controlled study of citalopram in adolescents with major depressive disorder.

Authors:  Anne-Liis von Knorring; Gunilla Ingrid Olsson; Per Hove Thomsen; Ole Michael Lemming; Agnes Hultén
Journal:  J Clin Psychopharmacol       Date:  2006-06       Impact factor: 3.153

Review 6.  ACNP Task Force report on SSRIs and suicidal behavior in youth.

Authors:  J John Mann; Graham Emslie; Ross J Baldessarini; William Beardslee; Jan A Fawcett; Frederick K Goodwin; Andrew C Leon; Herbert Y Meltzer; Neal D Ryan; David Shaffer; Karen D Wagner
Journal:  Neuropsychopharmacology       Date:  2006-03       Impact factor: 7.853

Review 7.  Selective serotonin reuptake inhibitors for unipolar depression: a systematic review of classic long-term randomized controlled trials.

Authors:  Dorian Deshauer; David Moher; Dean Fergusson; Ester Moher; Margaret Sampson; Jeremy Grimshaw
Journal:  CMAJ       Date:  2008-05-06       Impact factor: 8.262

8.  Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial.

Authors:  John March; Susan Silva; Stephen Petrycki; John Curry; Karen Wells; John Fairbank; Barbara Burns; Marisa Domino; Steven McNulty; Benedetto Vitiello; Joanne Severe
Journal:  JAMA       Date:  2004-08-18       Impact factor: 56.272

9.  Selective publication of antidepressant trials and its influence on apparent efficacy.

Authors:  Erick H Turner; Annette M Matthews; Eftihia Linardatos; Robert A Tell; Robert Rosenthal
Journal:  N Engl J Med       Date:  2008-01-17       Impact factor: 91.245

10.  An international, multicenter, placebo-controlled trial of paroxetine in adolescents with major depressive disorder.

Authors:  Ray Berard; Regan Fong; David J Carpenter; Christine Thomason; Christel Wilkinson
Journal:  J Child Adolesc Psychopharmacol       Date:  2006 Feb-Apr       Impact factor: 2.576

View more
  1 in total

1.  Outside the Black Box: Re-assessing Pediatric Antidepressant Prescription.

Authors:  Jacqueline A Sparks; Barry L Duncan
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2013-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.